Shares of Rigel Pharmaceuticals (RIGL) have gained 53.5% over the past four weeks to close the last trading session at $22.74, but there could still be a solid upside left in the stock if short-term ...

Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive have been highlighted in this Screen of The Week ...

Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) rallied 36% on Friday, the day after the company released a Q3 earnings report ...

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have received a consensus recommendation of “Hold” from the five brokerages that are currently covering the stock, Marketbeat ...

Market Square Moment” is a new platform to showcase large-scale art on a 20-by-50-foot-frame on the building facade of 8 ...

Rigel Pharmaceuticals Inc (RIGL) reports a 44% increase in net sales and achieves positive net income, driven by robust ...

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) traded up 4.8% during mid-day trading on Thursday after Piper Sandler raised their price target on the stock from $15.00 to $23.00 ...

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Rigel (RIGL – Research Report) today and set a price target of $57.00. Joseph Pantginis has given his Buy rating due to a ...

Rigel Pharmaceuticals Inc. (RIGL)股票飙升至52周新高，达到17.5美元的价格水平，标志着公司的一个重要里程碑。这一峰值反映了强劲的同比表现，过去一年股票涨幅高达120.29%。投资者对Rigel的市场地位和未来前景表现出越来越强的信心，这从股票强劲的上升轨迹中可见一斑，最终达到这一最新高点。52周新高证明了公司在竞争激烈的制药行业中的韧性和增长潜力。

Rigel Pharmaceuticals ( (RIGL)) has released its Q3 earnings. Here is a breakdown of the information Rigel Pharmaceuticals presented to its investors. Rigel Pharmaceuticals, Inc., based in South San ...

SOUTH SAN FRANCISCO, Calif. — SOUTH SAN FRANCISCO, Calif. — Rigel Pharmaceuticals Inc. (RIGL) on Thursday reported third-quarter net income of $12.4 million. The South San Francisco, California-based ...

周一，花旗维持对Rigel制药的积极展望，将该股票的目标价从此前的$40.00上调至$49.00，同时保持买入评级。这一调整是在Rigel的产品之一Gavreto报告销售额为$7.1百万后做出的，超过了分析师$2.8百万的预估和$4.1百万的一致预期。